ImmunoMind
PrivateLast Round
Accelerator
Sep 15, 2020
Total Funding Raised
$105,000
Company Overview
ImmunoMind is a biotechnology company that provides an open-source ecosystem for designing personalized immunotherapies and vaccines using systems immunology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoMind Comparables
Compare ImmunoMind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ozette | 84% | |
| ENPICOM | 78% | |
| Scailyte AG | 77% |
ImmunoMind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 15, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 1370% MoM.
- Sep 15, 2020
$105K raised led by SkyDeck.
ImmunoMind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmunoMind's valuation, stock price, and market status.
Is ImmunoMind a public or private company?
ImmunoMind is a private company.
What is the current stock price of ImmunoMind?
ImmunoMind is a private company with no public stock price. No recent secondary market data is available.
How much is ImmunoMind worth (valuation)?
Valuation information for ImmunoMind is not publicly available.
Can I buy ImmunoMind stock?
ImmunoMind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImmunoMind's last funding round?
Funding round information for ImmunoMind is not publicly available.
Who are the main investors in ImmunoMind?
Investor information for ImmunoMind is not publicly disclosed.
Will ImmunoMind IPO soon?
No public IPO plans have been announced for ImmunoMind.
How can I track ImmunoMind secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImmunoMind's secondary market activity and sign up for updates.